SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-022266
Filing Date
2024-05-09
Accepted
2024-05-09 16:27:12
Documents
52
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgls-20240331.htm   iXBRL 10-Q 1094791
2 EX-5.1 ex-51x20240331opinionofcoo.htm EX-5.1 13463
3 EX-31.1 ex-311x20240331.htm EX-31.1 9693
4 EX-31.2 ex-312x20240331.htm EX-31.2 9680
5 EX-32.1 ex-321x20240331.htm EX-32.1 9542
11 image.jpg GRAPHIC 2039
  Complete submission text file 0001628280-24-022266.txt   4800428

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20240331.xsd EX-101.SCH 30419
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20240331_cal.xml EX-101.CAL 55401
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20240331_def.xml EX-101.DEF 192828
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20240331_lab.xml EX-101.LAB 430665
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20240331_pre.xml EX-101.PRE 286678
56 EXTRACTED XBRL INSTANCE DOCUMENT rgls-20240331_htm.xml XML 479289
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 24931156
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)